FindTrial
Sign In

Usefulness of Chi3L1 in the prediction of airway remodeling and alveolar damage in the patients with Mycoplasma pneumoniae pneumonia

Usefulness of Chi3L1 in the prediction of airway remodeling and alveolar damage in the patients with Mycoplasma pneumoniae pneumonia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017429
Enrollment
Unknown
Registered
2018-07-30
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M. pneumonia pneumonia

Interventions

Case series:Nil

Sponsors

Guangdong Women and Children Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: From august 1, 2018 to july 31, 2019, 70 children with MPP were admitted to Guangdong Women and Children Hospital. All patients had symptoms and signs indicative of pneumonia at admission

Exclusion criteria

Exclusion criteria: pneumonia caused by virus bacteria, fungi, chlamydia and so on.

Design outcomes

Primary

MeasureTime frame
chi3l1;—

Countries

China

Contacts

Public ContactLilin Huang

Guangdong Women and Children Hospital

921295597@qq.com+86 13570433543

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026